Antivert (meclizine) for Vertigo and Dizziness in Multiple Sclerosis

Antivert (meclizine) is used to prevent and treat nausea, vomiting, and dizziness. Meclizine is an antihistamine that works by reducing the effects of natural histamine in the body. It can be prescribed for people with muscular sclerosis (MS).

Vertigo and dizziness are common symptoms of MS. People with MS may feel off-balance or light-headed. Less often, they experience vertigo sensation — a feeling that their surroundings are spinning around them. For MS patients, the symptoms are due to lesions between connections that coordinate visual, spatial, and other information to the brain to produce and maintain equilibrium. Brain and spinal cord lesions are common in MS patients.

Other conditions that might cause dizziness include middle ear inflammation and benign tumors on the acoustic nerve that connects the ear and the brain.

Meclizine is administered in a tablet, a chewable tablet, or a capsule. Typically, the drug is taken every 24 hours if needed, but patients should not take any more or less than prescribed by a doctor. For vertigo treatment, meclizine may be needed several times a day.

Common meclizine side effects may include headache, vomiting, dry mouth, tired feelings, or drowsiness.

There are several generic products available that are equivalent to Antivert.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.

Listen Here